NCT02663219

Brief Summary

The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable interventions to identify, recruit, link to care, retain in care, attain, and maintain viral suppression among HIV-infected men who have sex with men (MSM) in the United States (US).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
144

participants targeted

Target at P25-P50 for not_applicable hiv

Timeline
Completed

Started Jun 2016

Typical duration for not_applicable hiv

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 13, 2016

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 26, 2016

Completed
4 months until next milestone

Study Start

First participant enrolled

June 6, 2016

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 8, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 8, 2019

Completed
Last Updated

March 25, 2025

Status Verified

March 1, 2025

Enrollment Period

2.7 years

First QC Date

January 13, 2016

Last Update Submit

March 20, 2025

Conditions

Keywords

MSMARTCCMDAIDSHPTNACAPAFPEPRDS

Outcome Measures

Primary Outcomes (3)

  • HIV status at screening for each MSM recruited

    HIV status

    At Baseline

  • HIV viral load at screening for each MSM recruited

    HIV viral load

    12 months

  • HIV viral load at month 24 of participants randomized

    time driven HIV viral load

    24 months

Secondary Outcomes (11)

  • Date of recruitment for each man recruited by DC-RDS

    During recruitment period

  • Wave of recruitment for each man recruited by DC-RDS

    During recruitment period

  • HIV viral load of those randomized

    HIV viral load at Months 3, 6, 9, 12

  • Number of all care visits from randomization through the end of 12 months follow up

    Over 12 months

  • Time of all care visits from randomization through the end of 12 months follow up

    Over 12 months

  • +6 more secondary outcomes

Other Outcomes (6)

  • Health care utilization at baseline and 24 months

    Up to 24 months

  • Stigma at baseline and 24 months

    Up to 24 months

  • Number of contacts (text message, email, phone, in person) for each participant randomized to the CM intervention arm over follow-up

    Up to 24 months

  • +3 more other outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

The intervention arm will provide a Case Manager (CM) intervention package designed to enhance linkage to care, antiretroviral treatment (ART) initiation, treatment adherence and retention in care.

Behavioral: Intervention

Control

NO INTERVENTION

Standard of care

Interventions

InterventionBEHAVIORAL

The intervention arm will provide a Case Manager (CM) intervention package designed to enhance linkage to care, antiretroviral treatment (ART) initiation, treatment adherence and retention in care.

Also known as: Case Management
Intervention

Eligibility Criteria

Age16 Years+
Sexmale(Gender-based eligibility)
Gender Eligibility Detailsbiologically male
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals who meet all of the following criteria are eligible for study screening:
  • Biological male (at birth)
  • Self-report of history of anal intercourse with another man
  • years or older
  • Individuals who are eligible for screening and who meet all of the following criteria are eligible for enrollment into the CM intervention and SOC control arms:
  • HIV-infected, as defined in the HPTN 078 Study-Specific Procedures (SSP) Manual
  • Not virally suppressed (defined as HIV VL ≥ 1000 copies/ml)
  • Can receive HIV care at one of the participating clinics (as chosen by each site)
  • No current plan to relocate in the 24 months following enrollment

You may not qualify if:

  • Individuals who meet any of the following criteria will be excluded from study screening:
  • Unable or unwilling to provide consent/assent for study participation.
  • Active or previous participation in an HIV vaccine trial.
  • Any condition that, in the opinion of the Investigator of Record (IoR), would make participation in the study unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.
  • Individuals who are eligible for screening, but who meet the following criteria are excluded from enrollment into the CM intervention and SOC control arms:
  • Current participation in a linkage or ART adherence study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Alabama CRS

Birmingham, Alabama, 35294, United States

Location

Ponce de Leon CRS

Atlanta, Georgia, 30308-2012, United States

Location

Johns Hopkins Baltimore CRS

Baltimore, Maryland, 21287, United States

Location

Fenway Health CRS

Boston, Massachusetts, 02215-4302, United States

Location

Related Publications (2)

  • KM Mitchell, B Hoots, D Dimitrov, et al. Potential Impact on HIV Incidence of Increasing Viral Suppression among HIV- positive MSM in Baltimore: Mathematical Modelling for HPTN 078. HIV Research for Prevention (HIVR4P 2016). Chicago, October 17-21, 2016. Abstract OA10.04

    BACKGROUND
  • Maragh-Bass AC, Hucks-Ortiz C, Beyrer C, Remien RH, Mayer K, Del Rio C, Batey DS, Farley JE, Gamble T, Tolley EE. Multilevel Stigma and Its Associations with Medical Care Ratings Among Men Who Have Sex With Men in HPTN 078. J Prim Care Community Health. 2023 Jan-Dec;14:21501319231175362. doi: 10.1177/21501319231175362.

Related Links

MeSH Terms

Interventions

MethodsCase Management

Intervention Hierarchy (Ancestors)

Investigative TechniquesPatient Care PlanningComprehensive Health CarePatient Care ManagementHealth Services Administration

Study Officials

  • Chris Beyrer, MD/MPH

    Johns Hopkins University

    STUDY CHAIR
  • Robert H Remien, PhD

    Columbia University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 13, 2016

First Posted

January 26, 2016

Study Start

June 6, 2016

Primary Completion

February 8, 2019

Study Completion

February 8, 2019

Last Updated

March 25, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations